Microbio Co

Microbio Co Debt

The Debt of Microbio Co (4128.TWO) as of Nov 19, 2026 is 621.34 M TWD. In the previous year, Debt was 490.28 M TWD — a change of 26.73% (higher).

Debt

621.34 MTWD

YoY

26.73%

Last updated:

In 2023, Microbio Co's total debt was 621.34 M TWD, a 26.73% change from the 490.28 M TWD total debt recorded in the previous year.

The Microbio Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2016
510.88 M TWD
Jan 1, 2017
503.45 M TWD
Jan 1, 2018
150.08 M TWD
Jan 1, 2019
660.16 M TWD
Jan 1, 2020
508.66 M TWD
Jan 1, 2021
519.31 M TWD
Jan 1, 2022
490.28 M TWD
Jan 1, 2023
621.34 M TWD
The Microbio Co Debt history
YEARDebtYoY
621.34 MTWD+26.73%
490.28 MTWD-5.59%
519.31 MTWD+2.09%
508.66 MTWD-22.95%
660.16 MTWD+339.88%
150.08 MTWD-70.19%
503.45 MTWD-1.45%
510.88 MTWD+1.50%
503.32 MTWD+100.68%
250.81 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion. Microbio Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding Microbio Co's Debt Structure

Microbio Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Microbio Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Microbio Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Microbio Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Microbio Co stock

Debt of Microbio Co is 621.34 M TWD in 2023.

Debt of Microbio Co changed from 490.28 M TWD to 621.34 M TWD, representing a 26.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Microbio Co since 2006 – with annual values, charts, and detailed analysis.

Debt's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Microbio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Microbio Co

All Key Metrics — Microbio Co